On July 19, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 18, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 13, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA has issued its Enforcement Report for July 13, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.

On July 12, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA on July 8 posted its final guidance document intended to help animal food facilities develop food safety plans to comply with FDA’s Food Safety Modernization Act preventive controls for animal food regulations. The guidance includes information on the biological, chemical and physical hazards in the manufacturing, processing, packing and holding of animal food; the components of a food safety plan; and the importance of each component. It also details how to conduct a hazard analysis and develop a food safety plan, and identify and apply preventive controls, as well as how to comply with monitoring, verification and record-keeping requirements under the regulations.

On July 11, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 8, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 6-7, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA in recent days released updates to draft guidance documents it had previously issued on aspects of the Drug Supply Chain Security Act. The agency revised its 2014 draft guidance document on interoperability standards for the exchange of information on drugs (see 1411260013), as well as a guidance document it issued in 2017 on identifying “trading partners” under the DSCSA (see 1708210034).